---
schema_version: "secwatch.filing_event.v1"
accession: "0001625297-25-000046"
form_type: "8-K"
ticker: "INDV"
cik: "0001625297"
company_name: "Indivior Pharmaceuticals, Inc."
filed_at: "2025-06-30T23:59:59+00:00"
generated_at: "2026-05-18T13:10:57.254760+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Indivior added to Russell 2000 and 3000 indexes effective June 30, 2025

## Summary
- Inclusion follows 2025 Russell indexes annual reconstitution; membership lasts one year.
- CEO notes 85% of 2024 net revenue was U.S.-generated, mainly from SUBLOCADE.
- About $10.6 trillion in assets benchmarked to U.S. Russell indexes (FTSE Russell data).
- Stock also automatically added to corresponding growth and value indexes.

## SEC filing metadata
- accession: 0001625297-25-000046
- form_type: 8-K
- ticker: INDV
- cik: 0001625297
- company_name: Indivior Pharmaceuticals, Inc.
- filed_at: 2025-06-30T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1625297/000162529725000046/0001625297-25-000046-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1625297/000162529725000046/indv-20250630.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001625297-25-000046
- JSON: https://secwatch.observer/filing/0001625297-25-000046.json
- Plain text: https://secwatch.observer/filing/0001625297-25-000046.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.